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The aim of this study was to define the clinical feasibility of planar 
myocardial 18F-fluorodeoxyglucose (FDG) imaging and to as­
sess the relation between 201TI, FDG and left ventricular function 
early after myocardial infarction. Methods; Fifty-one patients 
were studied 5 ±  2 days after infarction. Scintigraphic images 
were visually and quantitatively analyzed using a circumferential 
profiles technique. FDG uptake was normalized to the area with 
maximal 201 Tl uptake. Scintigraphic data were compared with 
left ventricular wall motion as assessed by ventriculography in 22 
patients. Relative regional 201TI uptake was categorized as nor­
mal (>  75%  of peak activity), moderately reduced (50% -75% ) or 
severely reduced (<  50%). These tracer defects were consid­
ered viable if FDG uptake exceeded 201TI uptake by >  20%  
and/or if FDG uptake was normal (>  75%). All regions with FDG  
uptake 20%  less than 201TI uptake were considered nonviable. 
Results: Four hundred forty-one myocardial regions were ana­
lyzed; 200 showed normal 201 Tl uptake, 241 had reduced up­
take, 191 had moderately reduced ^ T l  uptake and 50 regions 
had severely reduced uptake. Viability for moderately and se­
verely reduced regions was observed in 62% and 48%, respec­
tively. A concordance between flow and metabolism was ob­
served in 38%  and 52%, respectively. Conclusion: Myocardial 
FDG imaging is feasible with standard gamma camera systems 
and enables the identification of regions With preserved glucose 
metabolism in patients shortly after infarction.
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t i n d e r  normal physiologic conditions, and particularly 
in the fasting state, fatty acids are the preferred substrates 
for myocardial energy production (7). Only a minority of 
the energy is obtained from glucose and lactate. Both an­
imal and clinical studies have shown that glucose utiliza-
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tion is enhanced in ischemic but viable myocardium. This 
increased myocardial glucose utilization can be traced non- 
invasively by PET using 18F-fluorodeoxyglucose (FDG) 
(2,5). Tillisch et al. and Tamaki et al. {4,5) showed recov­
ery of wall motion abnormalities in patients undergoing 
coronary bypass surgery could be predicted by normal or 
enhanced myocardial FDG uptake before revasculariza­
tion. These studies have validated FDG as a valuable 
tracer of myocardial viability.
It is possible to visualize myocardial FDG uptake with a
standard gamma camera and a 511-keV collimator (6-8).
i
Because gamma camera systems are more readily available 
than PET systems, development of planar FDG scintigra­
phy to assess myocardial viability may enable the applica­
tion of FDG in routine clinical practice. We performed a 
study in patients shortly after myocardial infarction to de­
fine the clinical feasibility of planar myocardial FDG imag­
ing and to investigate the relationship between 201T1 and 
FDG in myocardial areas with normal and abnormal left 
ventricular function.
MATERIALS AND METHODS 
Patients
The study was approved by the Ethical Committee on Human 
Research of the Free University Hospital. Fifty-one consecutive 
patients (41 men; mean age 60 ± 12 yr) admitted to the coronaiy 
care unit with myocardial infarction were studied. All patients 
were admitted with a typical history of prolonged chest pain, 
transiently elevated serum enzyme levels including CK-MB frac­
tions, and electrocardiographic signs of either a Q-wave or a 
non-Q-wave infarction. Forty-four patients had Q-wave infarction 
and seven patients had non-Q-wave infarction by electrocardio­
graphic criteria. Thirty-three patients were treated with thrombo­
lytic agents in the acute stage of infarction.
Exclusion criteria for entering the study were unstable angina 
pectoris, insulin-dependent diabetes mellitus, severe congestive 
heart failure (Killip class III-IV) and major noncardiac disease. 
After informed consent was obtained, all patients underwent scin­
tigraphic evaluation by 201T1 and FDG at rest on the same day; 
which was within 5 ± 2  days of infarction.
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Thallium-201 Scintigraphy
Rest 201T1 scintigraphy was performed in the morning after a 
light meal. Ten to 15 min after intravenous administration of 74-90 
MBq 201T1 views were obtained in the standard left anterior ob­
lique 45 (LA045), anterior and left anterior oblique 70 (LA070) 
positions. The gamma camera was equipped with a 9-mm crystal 
and a low-energy all-purpose collimator. Images were obtained 
using 8 min per view in the zoom mode in a wordframe matrix of 
128 x 128 pixels and the scintigraphic data were stored on disk. 
To ensure correct patient positioning during FDG imaging, the 
scintigraphically determined position of the center of the left ven­
tricle was marked on the chest of the patient using a marker (57Co) 
and a pen with water-insoluble ink after each 201T1 image.
FDG Scintigraphy
Deoxyglucose was labeled with 18F at the Radionuclide Center 
of the Free University; no carrier was added to the 1SF. A typical 
purity of greater than 95% was obtained. Transportation to the 
hospital lasted 20 min. Forty-five minutes before intravenous ad­
ministration of 185 MBq FDG, an oral glucose load of 20-50 g was 
given together with a light carbohydrate meal. The meal was to 
prevent fasting conditions during the study, promote FDG uptake 
and minimize the heterogeneity of myocardial FDG uptake {9,10). 
Forty minutes after injection, scintigraphy was started. Standard 
LA045, anterior and LA070 views were obtained. The same 
conventional Anger gamma camera equipped with a 511-keV col­
limator (van Mullekom, Nuclear Fields, Boxmeer, The Nether­
lands) was used. Starting with a 360-keV collimator, adjustment to 
a 511-keV collimator was achieved by increasing the bore length 
and septal thickness. The hole diameter had to be increased to 4.6 
mm to ascertain that the collimator weight did not exceed 150 kg. 
The septal thickness of this collimator is 2.11 mm and the spatial 
resolution of this imaging system using a line spread function 
FWHM has been estimated to be 14 mm for 18F in 10 cm water (7).
The FDG images were acquired with an energy window of 20% 
around the photopeak of 18F (511 keV) in the zoom mode in a 
wordframe matrix of 128 X 128 pixels during 8 min per view. All 
scintigraphic data were stored on disk. Blood samples were taken 
to measure plasma glucose and insulin levels shortly before the 
administration of FDG in 23 patients.
Cardiac Catheterization
Cardiac catheterization with coronary angiography and left 
ventriculography was performed in 22 patients using the Judkins' 
technique. Cardiac catheterization was performed within 6 ±  5 
days of infarction. Left ventriculograms were obtained in all pa­
tients in a 30° right anterior oblique (RA030) projection and in the 
60° left anterior oblique (LA060) position. The ventriculograms 
and coronary angiograms were reviewed by two experienced ob­
servers without knowledge of the scintigraphic data. Maximal 
luminal diameter narrowing of each major coronary artery was 
estimated visually and differences in interpretation were resolved 
by consensus with a third observer. A luminal diameter narrowing 
greater than 50% was considered significant.
Left ventricular wall motion was assessed qualitatively by di­
viding the left ventricle into anterior, apical and inferior regions in 
the RA030 view and the septal, inferoapical and posterolateral 
regions in the LA060 view. Wall motion was scored as normal, 
hypokinetic, akinetic or dyskinetic.
Data Analysis
FDG images were projected on a monitor screen without back­
ground correction or smoothing for visual interpretation by two
experienced observers. Scintigrams were visually scored as good, 
moderate or poor. Anterior views were used to draw regions of 
interest (ROI) over myocardium with qualitatively normal 201T1 
and FDG uptake. Scintigraphic information combined with data 
from coronary angiography was used to assure that ROIs were 
drawn in flow areas of normal coronary arteries when these an­
giographic data were available. In addition, ROIs were drawn 
over the lung area adjacent to the left ventricle and over the liver 
area. The numbers of pixels per myocardial, lung and liver ROIs 
were 100,425 and 115, respectively in all patients. Heart/lung and 
heart/liver ratios for 201T1 and FDG were calculated from the 
counts per pixel in the ROIs.
Quantitative Analysis of Myocardial Thallium and 
FDG Images
The images were quantitatively analyzed with an operator- 
interactive computer program. This program involved the follow­
ing steps. A circle was drawn around the left ventricle. The 
interpolative background subtraction technique as described by 
Goris et al. (11) and modified by Watson et al. (12) using a 
proximity weighting function was applied. After background sub­
traction, nine-point image smoothing was performed. The left 
ventricle was divided into 60 radii spaced 6° apart, originating 
from the center of the ventricle. Along each radius, the pixel with 
maximum 201T1 or FDG activity was chosen and plotted as the 
number of counts versus angle. The combination of all 60 radii 
resulted in a circumferential profile of myocardial uptake. Profiles 
were then aligned such that the 90° radius in each view corre­
sponded to the visually located apex. The outflow tract radii, 
chosen between 204 and 330° (13), were excluded from further 
data analysis. In addition, the left ventricle without the outflow 
tract was divided into 13 sectors of 18°. Of each myocardial view, 
the myocardial sector with the maximal 201T1 uptake was used as 
the individual reference sector for the 201T1 and FDG study. FDG 
uptake within this sector was considered 100% and FDG activities 
of other sectors were normalized to this maximal 201T1 uptake. 
Thus, relative myocardial 201T1 and FDG uptake in sectors were 
expressed as a percentage of this reference region. The three 
planar images were divided into a total of nine regions (Fig. 1). 
Average relative 201T1 and FDG uptake for these regions were 
calculated. Relative regional 201T1 uptake was categorized into 
normal 75% of peak activity), moderately reduced (50%—75%) 
and severely reduced (< 50%). These tracer defects were classi­
fied as viable and nonviable. Regions were considered viable if 
FDG uptake exceeded 201Tl uptake by 20% or more or if FDG 
uptake was normal (> 75%). All regions with FDG uptake less 
than 20% of 201T1 uptake were considered nonviable.
Imaging two tracers with different photon energies may result 
in different circumferential profiles. For this purpose, a phantom 
study was performed with an ellipsoidal sphere with an inner and 
outer wall. In the 1-cm space between these walls, a small com­
partment (2 x 2  cm) was introduced to create a tracer defect. Both 
the sphere and the defect were filled with 201rn and FDG activity. 
If the defect activity was less than 33%, the normalized profiles of 
201T1 and FDG differed less than 7% from each other. If the defect 
activity was more than 60%, the normalized 201T1 and FDG pro­
files differed less than 2% from each other. Hence, a 20% criterion 
for the difference between normalized 201T1 and FDG profiles can 
safely be used for the detection of myocardial viability.
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FIGURE 1. Myocardial regions used for the quantitative analysis of the scintigrams. ANT =  anterior; LA045 = left anterior oblique, 45°; 
LA070 =  left anterior oblique, 70°.
Comparison of Left Ventricular Wall Motion with 
Scintigraphic Data
For correlation of wall motion and scintigraphic data, corre­
sponding myocardial regions were compared. The anterior scin­
tigrams were compared with the RA030 ventriculograms and the 
LA045 scintigrams with the LA060 ventriculograms (.14,15).
Statistical Analysis
Values are expressed as mean ± standard deviation. Statistical 
analysis was performed with the Student's t-test for paired and 
unpaired data. A p value < 0.05 was considered statistically 
significant.
RESULTS 
image Quality
Visually, the image quality of 27 (53%) FDG studies was 
good, 17 (33%) were moderate and 5 (10%) were poor. Two 
of the five poor FDG studies were of such bad quality that 
they were uninterpretable and were excluded from further 
data analysis. Heart-to-lung ratios of 201T1 images were
2.37 ± 0.44 and o f FDG, 2.45 ± 0.39 (p = ns). Heart-to- 
liver ratios were 1.06 ±  0.19 and 1.78 ± 0.34 (p < 0.001), 
respectively.
Regional Analysis
Figure 2 shows the relation of relative regional 201T1 and
FDG uptake (FDG = 0.68T1 + 35.59; r = 0.63; n = 441).
FDG uptake in normal myocardium was homogeneously 
distributed with a FDG/201T1 ratio of 1.10 ± 0.15. The 
FDG/201T1 ratio in abnormal myocardium was 1.30 ± 0.27 
(p < 0.05 versus normal myocardium). Figure 3 shows a 
flow chart of the analyzed myocardial regions. Four hun­
dred forty-one myocardial regions was analyzed for 201T1 
and FDG uptake: 200 regions showed normal 201T1 uptake, 
241 regions had reduced uptake, 191 had moderately re­
duced 201T1 uptake (50-75%) and 50 regions had severely 
reduced uptake (<  50%).
Viability was preserved in 62% and 48% (p = ns) of
moderately reduced and severely reduced regions. A  con­
cordance between blood flow and metabolism was ob­
served in 38% and 52%, respectively. The average 201T1 
and FDG uptake in relation to the severity of reduction in 
flow is expressed in Table 1. Thallium uptake differs in the 
normal, moderately and severely reduced regions, but it 
cannot differentiate between viable and nonviable regions 
within severely reduced regions (43.1% versus 42.0%).
Coronary Angiography and Regional Wall Motion
Nine patients had single-vessel disease, seven patients 
had double-vessel disease and six patients had triple-vessel 
disease. The mean left ventricular ejection fraction was 
49% ± 9%. Ninety myocardial areas showed normal wall 
motion on ventriculography (Fig. 4). The average 201T1 
uptake was 75.7% ±  11.2% (p < 0.01 versus hypokinetic 
and akinetic regions) and FDG uptake w as 86.2% ±  13.0%
201 Tl uptake (% of peak activity)
FIGURE 2. Scatter plot and regression analysis of relative 201 Tl 
and relative FDG uptake in myocardial regions with normal and 
reduced 201 Tl uptake.
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FIGURE 3. Row chart of the analyzed myocardial regions.
FIGURE 4. Bar graph showing relative 201TI and FDG uptake in 
relation to left ventricular wall motion.
(p = ns versus hypokinetic regions; p < 0.01 versus aki­
netic regions), respectively, in these areas.
Twenty-nine hypokinetic myocardial areas were ob­
served. The average 201T1 uptake was moderately reduced 
in these regions (65.8% ± 12.9%, p = ns versus akinetic 
regions), but FDG was comparatively increased (86.0% ±  
18.7%, p = ns versus akinetic regions). Twenty-four (83%) 
hypokinetic areas were considered viable using the viabil­
ity definitions, and five regions (17%) were considered 
nonviabie.
In the 13 areas with akinesia, the average 2Q1T1 uptake 
was 65.7% ± 16.9% and the FDG uptake was 78.4% ±
Figure 5. Figure 6 shows an example of a mismatch be« 
tween flow and metabolism.
Plasma Glucose and Insulin Levels
Plasma glucose and insulin levels were, respectively, 
6.8 ± 1.4 mmole/liter and 43.7 ±  19.1 mU/liter.
DISCUSSION
We have described the use of planar myocardial FD G  
imaging in patients shortly after myocardial infarction us­
ing a rest 201rn  and FDG protocol. Regional left ventricular 
function was correlated to regional 201T1 and FDG uptake.
Planar FDG imaging yielded images of adequate quality 
in most patients. Seventy-six percent of the patients had
17.1% (p = ns versus hypokinetic regions). Nine (69%) normal or rdativel increased FDG uptake within the in-
regions were viable using the definitions for viability and farct area> which babl indicates the presence of viable
four regions (31%) were nonviabie. Viable myocardial re- myocardial tissue. This incidence is in line with previous
gions were detected in 37 (76%) patients. Thirty patients FDq studies after myocardiai infarction. Signs of residual
wah EOT signs of Q-wave mfarcUon had myocardial areas ischemia after infarctk)n were r ted in 55%_77% of
with viability. An example of scintigraphic images of a 
patient with a match in 201T1 and FDG uptake is shown in
TABLE 1
Average Regional201 Tl and FDG Uptake in Regions with 
Normal, Moderately Reduced (50-75%) and Severely
Reduced (<  50%) 201TI Uptake
Regions
Normal
50%~75%
Average 
201 Tl uptake
Average 
18FDG uptake
<50%
Total group
Nonviabie
Viable
Total group
Nonviabie
Viable
83.6 ± 5.5
64.5 ± 7.3 
61.1 ±6.9
66.6 ± 6.8+
42.5 ± 6.1
42.0 ± 6.2
43.1 ± 6.0
92.2 ± 11.9
79.3 ± 14.4*
65.4 ± 7.3*
87.8 ± 10.5
63.2 ± 13.6*
52.8 ± 8.1*
74.5 ± 8.2*
*p < 0.01 vs. FDG uptake in normal regions.
fp < 0.001 vs.201 Tl uptake in nonviabie moderately reduced regions.
patients (2,8,16,17).
Table 1 and Figure 3 show that FDG uptake can be  
preserved (79.3%), especially in regions with moderately 
reduced 2Q1T1 uptake. This is in contrast to FDG uptake in 
regions with severely reduced 201T1 uptake (63.2%), but it 
is similar to the results o f a study by Kalff et al. (18). T hey  
found that a blood flow reduction of 50% did not change 
relative glucose utilization in ischemic canine myocardium. 
In contrast, low flow conditions resulted in marked impair­
ment of FDG uptake. Our findings also correlate with the 
study by Dilsizian et aL (19) who found that the magnitude 
of 201T1 uptake after reinjection could distinguish between  
viable and nonviabie myocardium. Mild-to-moderate 201T1 
defects may represent viable myocardium. With planar 
scintigraphy, we found a high incidence of residual tissue  
viability in ventricular regions with reduced flow and im­
paired function during the subacute phase of myocardial 
infarction. These results indicate, as do previous FDG - 
PET studies, that (1) viable myocardium can be character­
ized by a small decrease in 201T1 uptake combined w ith a 
normal FDG uptake, and (2) viable myocardium can be
978
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FIGURE 5. Quantitative analysis (A) and left anterior oblique, 70° 
view (B) o f201 Tl (left) and FDG (right) scintigram. The reduction in 
both 201Tl and FDG uptake in the anterior region of the left ventricle 
showed concordance (nonviable tissue).
FIGURE 6. Quantitative analysis (A) and left anterior oblique, 45° 
view (B) of 201TI (left) and FDG (right) scintigram. A concordant 
reduction in the inferior uptake of 201TI and FDG can be observed. 
The relative enhanced septal uptake of FDG to 201TI exceeds the 
criteria for viability.
characterized by a FDG/201! !  mismatch (> 20%) with a 
m ore profound perfusion deficit and relative increase in 
FD G  uptake. Nonviable myocardium is characterized by a 
matched FDG/201! !  defect.
Early Imaging
Early identification o f viable but jeopardized myocar­
dium would support aggressive therapy to salvage endan­
gered myocardial tissue. We found a high incidence of 
tissue viability in the subacute phase of infarction. As was 
shown by Schwaiger et al. (2 ), absence of residual tissue 
metabolism shortly after infarction is associated with irre­
versible injury, while remaining of metabolic activity indi­
cates regions with a variable outcome. Although polymor­
phonuclear leukocytes accumulate in necrotic tissue as 
early as 4 hr after reperfusion of ischemic canine myocar­
dium, preserved FDG uptake in the area of infarction is 
likely to reflect the metabolism of viable myocytes and is 
not just an inflammatory reaction, as was shown by a study 
of Wijns et al. (20). Our results show that FDG imaging to 
assess viability during the subacute phase of infarction is 
feasible; however, the need for complementary revascular­
ization has to be determined.
Clinical Relevance
The clinical relevance and prognostic importance of the
coronary arteiy disease was shown by Eitzman et al. (21) 
and Tamaki et aL (22). Their findings suggested that pa­
tients with impaired left ventricular function and metabolic 
evidence of myocardial ischemia appeared to have the 
most clinical benefit from a revascularization procedure. 
Whether these findings also apply to patients with recent 
myocardial infarction has to be established.
Left Ventricular Function
Williams et al. (8) performed planar FDG imaging in 
patients after myocardial infarction who were evaluated 
before and after revascularization. Of 46 fixed 201rn  defects 
(exercise 201rn  and 24-hr redistribution imaging) preopera- 
tively, 30 defects demonstrated improvement in regional 
exercise 201T1 uptake or regional systolic function after 
revascularization. FDG-201T1 mismatches were present in 
83% of these regions but were absent in the majority of the 
functionally unimproved regions. Therefore, their data 
suggest that viable myocardium can be identified using 
planar FDG scintigraphy. Our data indicate also that the 
detection of viability with the planar approach if feasible. 
Most regions with normal left ventricular function had a 
normal 201T1 and FDG uptake. Hypokinetic regions 
showed a clear discordance between flow and metabolism, 
indicating the shift in energy production from free fatty 
acids to glucose. Three regions with a severely reduced
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2,)1T1 uptake and a concordant low FDG uptake (< 50%) 
were akinetic at ventriculography. These regions probably 
represent real scar tissue. The other akinetic myocardial 
regions had either a mild 201T1 defect or increased FDG 
uptake. Thus akinetic regions may represent scarred, hi­
bernating or stunned myocardium. It supports previous 
findings that evaluation of regional function shortly after 
the onset of infarction may fail to distinguish necrotic from 
viable myocardium. Additional information about viability 
from metabolic studies or from 201T1 activity are needed 
before proper clinical decisions can be made.
Methodologic Considerations
For viability assessment, myocardial FDG uptake 
should be related to a blood flow tracer {4,17). For this 
purpose, we used 201T1 because early 201T1 imaging reflects 
blood flow distribution in the myocardium (23).
The metabolic tracer, FDG, competes with glucose for 
phosphorylation by the enzyme hexokinase. In the myo­
cardial cell, FDG is phosphorylated and trapped because 
FDG-6-PO4 cannot be further metabolized (24,25). In isch­
emic myocardium, glucose becomes the major source of 
energy and may therefore lead to increased FDG uptake 
relative to nonischemic myocardium. This is the patho­
physiological basis for normalization of FDG uptake to the 
region revealing maximal 201T1 uptake. Because 201T1 up­
take depends on blood flow, oxygen consumption and 
myocardial mass, the region that shows maximal 201T1 up­
take represents the most “normal” myocardium.
Although planar 511-keV scintigraphy will not meet the 
standards of PET in terms of resolution and quantitation, 
the application of planar imaging systems seems justified, 
because, as Tillisch et al. (4) reported, only large myocar­
dial areas with flow/metabolism mismatch improved after 
surgical revascularization.
Although overlap of myocardial activity from normal 
myocardium may mask areas with ischemia or infarction, 
from the data of Williams et al. (£), it can be inferred that 
viability can be demonstrated with planar imaging.
The fact that most myocardial areas with normal func­
tion had 201T1 as well as FDG uptake of 75% or more 
supports the cut-off point of the lower limit of normal at 
75% and the definition of viability. These criteria have been 
previously used by others (26) and are also supported by 
our experience with 201T1 and FDG studies in 12 normal 
individuals (unpublished data), although it is acknowledged 
that revascularization data demonstrating improved re­
gional function are needed to confirm these findings. Sev­
enteen percent of hypokinetic regions was considered non- 
viable using the criteria for viability. This may have been
caused by qualitative visual analysis of the wall motion 
data.
It has been shown that 201T1 reinjection studies
(19,27,28) can be performed to detect myocardial tissue
viability. Our findings suggest that rest imaging, without
the need of exercise-induced ischemia, may also identify 
viability.
The lack of 201T1 rest-redistribution data is a major lim­
itation of our study; however, this was not the primary goal 
of our study. In theory, many of the regions with reduced 
201T1 uptake but preserved FDG uptake would show 201T1 
redistribution if late 201T1 imaging had been performed. 
Thus, the relative value of planar FDG scintigraphy com­
pared to PET and compared to 201T1 reinjection and rest- 
redistribution studies needs to be established. A lso, the 
additional value of planar FDG scintigraphy to rest-redis­
tribution imaging protocols needs investigation.
CONCLUSION
Myocardial FDG imaging is feasible with a standard 
gamma camera in patients shortly after myocardial infarc­
tion. Uptake of FDG in myocardial regions with normal 
201T1 uptake and normal left ventricular function is rela­
tively homogeneously distributed; in regions with reduced 
201T1 uptake and abnormal function, it was significantly 
more heterogeneous due to the presence of relatively in­
creased FDG uptake to flow. A  considerable number o f  
infarct patients (76%) had viable regions within the infarct 
area. Because an earlier planar FDG study has indicated 
that increased FDG uptake is related to functional recov­
ery after revascularization, further studies are justified to 
evaluate the clinical relevance of planar myocardial FDG  
imaging.
Finally, because gamma cameras are used in the major­
ity of community hospitals and because the physical half- 
life of 1SF allows offsite use of FDG, application in routine 
clinical practice may be possible for viability assessment, 
risk-stratification and prediction of functional recovery af­
ter myocardial infarction.
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